All persons or entities that purchased or otherwise acquired common shares of Depomed, Inc., n/k/a Assertio Therapeutics, Inc. (“Depomed” or the “Company”) from July 29, 2015 to August 7, 2017, inclusive.
Disbursed
July 28, 2015 - August 07, 2017
July 28, 2022
July 07, 2022
Analytics Consulting, LLC
Depomed (n/k/a Assertio Therapeutics) Securities Litigationc/o Analytics Consulting LLCP.O. Box 2004Chanhassen, MN 55317-2004
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.